Pediatric Rheumatology

pediatric rheumatology banner

Latest News

Juvenile Idiopathic Arthritis Increases Risk of Postpartum Complications

Juvenile Idiopathic Arthritis Increases Risk of Postpartum Complications

Ongoing inflammation related to JIA may put first-time mothers at risk for complications.

Cardiovascular Risks in JIA Linked to Serum Vitamin D Level

Cardiovascular Risks in JIA Linked to Serum Vitamin D Level

Thirty controls were compared with 30 patients with juvenile idiopathic arthritis to determine the link between vitamin D and CVD.

Diffuse Alveolar Hemorrhage in SLE Associated With Serious Disease Flare

Diffuse Alveolar Hemorrhage in SLE Associated With Serious Disease Flare

This condition is associated with serious disease flare complicated by sepsis and a high mortality rate.

Guidelines for Peri-Op Care in Rheumatic Disease

Guidelines for Peri-Op Care in Rheumatic Disease

These guidelines address the use of antirheumatic drugs for adults with RA, SpA, JIA, and SLE undergoing THA or TKA.

ANG-2 as Disease Marker in Children With Juvenile Idiopathic Arthritis

ANG-2 as Disease Marker in Children With Juvenile Idiopathic Arthritis

When combined with ultrasound examination, ANG-2 can help lead to the appropriate therapy for JIA.

Diagnosing Pediatric Lyme Arthritis

Diagnosing Pediatric Lyme Arthritis

Children are some of the most susceptible to Lyme disease. In many children, joint inflammation may be the first symptom.

Juvenile Idiopathic Arthritis Treatment With TNFIs Linked to Infection Risk

Juvenile Idiopathic Arthritis Treatment With TNFIs Linked to Infection Risk

Clinicians should consider the risk/benefit of prescribing TNFIs to children with idiopathic arthritis.

Muscle MRI as Complementary Diagnostic Tool for Juvenile Dermatomyositis

Muscle MRI as Complementary Diagnostic Tool for Juvenile Dermatomyositis

Muscle magnetic resonance imaging may complement a physician's objective assessment in juvenile dermatomyositis, although negative MRI findings should not preclude treatment continuation.

MTX  Adalimumab Effective in JIA-Associated Uveitis

MTX + Adalimumab Effective in JIA-Associated Uveitis

In children with active juvenile idiopathic arthritis, the treatment combination controls eye inflammation.

Tocilizumab Highly Effective in Refractory Juvenile Idiopathic Arthritis-associated Uveitis

Tocilizumab Highly Effective in Refractory Juvenile Idiopathic Arthritis-associated Uveitis

Tocilizumab therapy showed rapid improvement in ocular parameters for uveitis in juvenile idiopathic arthritis patients.

Sign Up for Free e-newsletters